|
1
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hohla F, Winder T, Greil R, Rick FG, Block
NL and Schally AV: Targeted therapy in advanced metastatic
colorectal cancer: Current concepts and perspectives. World J
Gastroenterol. 20:6102–6112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fadeel B and Orrenius S: Apoptosis: A
basic biological phenomenon with wide-ranging implications in human
disease. J Intern Med. 258:479–517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walczak H and Krammer PH: The CD95
(APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res.
256:58–66. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lavrik IN: Systems biology of apoptosis
signaling networks. Curr Opin Biotechnol. 21:551–555. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li ZY, Yang Y, Ming M and Liu B:
Mitochondrial ROS generation for regulation of autophagic pathways
in cancer. Biochem Biophys Res Commun. 414:5–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakanishi A, Wada Y, Kitagishi Y and
Matsuda S: Link between PI3K/AKT/PTEN pathway and NOX protein in
diseases. Aging Dis. 5:203–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pandurangan AK: Potential targets for
prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt
pathways. Asian Pac J Cancer Prev. 14:2201–2205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Danielsen SA, Eide PW, Nesbakken A, Guren
T, Leithe E and Lothe RA: Portrait of the PI3K/AKT pathway in
colorectal cancer. Biochim Biophys Acta. 1855:104–121. 2015.
|
|
11
|
Yang G, Li X, Li X, Wang L, Li J, Song X,
Chen J, Guo Y, Sun X, Wang S, et al: Traditional chinese medicine
in cancer care: A review of case series published in the Chinese
literature. Evid Based Complement Alternat Med. 2012:7510462012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Feng Y, Wang N, Cheung F, Tan HY,
Zhong S, Li C and Kobayashi S: Chinese medicines induce cell death:
The molecular and cellular mechanisms for cancer therapy. Biomed
Res Int. 2014:5303422014.PubMed/NCBI
|
|
13
|
Li J, Lu C, Jiang M, Niu X, Guo H, Li L,
Bian Z, Lin N and Lu A: Traditional chinese medicine-based network
pharmacology could lead to new multicompound drug discovery. Evid
Based Complement Alternat Med. 2012:1497622012.
|
|
14
|
Cha WS, Oh JH, Park HJ, Ahn SW, Hong SY
and Kim NI: Historical difference between traditional Korean
medicine and traditional Chinese medicine. Neurol Res. 29(Suppl 1):
S5–S9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwon T, Rho JK, Lee JC, Park YH, Shin HJ,
Cho S, Kang YK, Kim BY, Yoon DY and Yu DY: An important role for
peroxiredoxin II in survival of A549 lung cancer cells resistant to
gefitinib. Exp Mol Med. 47:e1652015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim YS, Li XF, Kang KH, Ryu B and Kim SK:
Stigmasterol isolated from marine microalgae Navicula incerta
induces apoptosis in human hepatoma HepG2 cells. BMB Rep.
47:433–438. 2014. View Article : Google Scholar :
|
|
17
|
Song JL, Choi JH, Seo JH, Kil JH and Park
KY: Antioxidative effects of fermented sesame sauce against
hydrogen peroxide-induced oxidative damage in LLC-PK1 porcine renal
tubule cells. Nutr Res Pract. 8:138–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kadenbach B, Arnold S, Lee I and Hüttemann
M: The possible role of cytochrome c oxidase in stress-induced
apoptosis and degenerative diseases. Biochim Biophys Acta.
1655:400–408. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scorrano L and Korsmeyer SJ: Mechanisms of
cytochrome c release by proapoptotic BCL-2 family members. Biochem
Biophys Res Commun. 304:437–444. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Degli Esposti M and Dive C: Mitochondrial
membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun.
304:455–461. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karbowski M, Norris KL, Cleland MM, Jeong
SY and Youle RJ: Role of Bax and Bak in mitochondrial
morphogenesis. Nature. 443:658–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duriez PJ and Shah GM: Cleavage of
poly(ADP-ribose) polymerase: A sensitive parameter to study cell
death. Biochem Cell Biol. 75:337–349. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Danson S, Dean E, Dive C and Ranson M:
IAPs as a target for anticancer therapy. Curr Cancer Drug Targets.
7:785–794. 2007. View Article : Google Scholar
|
|
24
|
de Graaf AO, de Witte T and Jansen JH:
Inhibitor of apoptosis proteins: New therapeutic targets in
hematological cancer? Leukemia. 18:1751–1759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fleury C, Mignotte B and Vayssière JL:
Mitochondrial reactive oxygen species in cell death signaling.
Biochimie. 84:131–141. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hensley P, Mishra M and Kyprianou N:
Targeting caspases in cancer therapeutics. Biol Chem. 394:831–843.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fiandalo MV and Kyprianou N: Caspase
control: Protagonists of cancer cell apoptosis. Exp Oncol.
34:165–175. 2012.PubMed/NCBI
|
|
30
|
Tomek M, Akiyama T and Dass CR: Role of
Bcl-2 in tumour cell survival and implications for pharmacotherapy.
J Pharm Pharmacol. 64:1695–1702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koehler BC, Jäger D and Schulze-Bergkamen
H: Targeting cell death signaling in colorectal cancer: Current
strategies and future perspectives. World J Gastroenterol.
20:1923–1934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qiao L and Wong BC: Targeting apoptosis as
an approach for gastrointestinal cancer therapy. Drug Resist Updat.
12:55–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marone R, Cmiljanovic V, Giese B and
Wymann MP: Targeting phosphoinositide 3-kinase: Moving towards
therapy. Biochim Biophys Acta. 1784:159–185. 2008. View Article : Google Scholar
|
|
34
|
Moral M and Paramio JM: Akt pathway as a
target for therapeutic intervention in HNSCC. Histol Histopathol.
23:1269–1278. 2008.PubMed/NCBI
|
|
35
|
Kardeh S, Ashkani-Esfahani S and Alizadeh
AM: Paradoxical action of reactive oxygen species in creation and
therapy of cancer. Eur J Pharmacol. 735:150–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matés JM, Segura JA, Alonso FJ and Márquez
J: Oxidative stress in apoptosis and cancer: An update. Arch
Toxicol. 86:1649–1665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jourdain A and Martinou JC: Mitochondrial
outer-membrane permeabilization and remodelling in apoptosis. Int J
Biochem Cell Biol. 41:1884–1889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Seo K, Ki SH and Shin SM: Methylglyoxal
induces mitochondrial dysfunction and cell death in liver. Toxicol
Res. 30:193–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asakura T and Ohkawa K: Chemotherapeutic
agents that induce mitochondrial apoptosis. Curr Cancer Drug
Targets. 4:577–590. 2004. View Article : Google Scholar : PubMed/NCBI
|
